RICHMOND, Va., Sept. 24, 2019 /PRNewswire/ -- The Hilb Group, LLC ("THG") announced today the acquisition of North Carolina-based Josh Williams Enterprises, Inc. d/b/a WNC Health Insurance ("WNC"). The transaction became effective September 1, 2019.

TEL-AVIV, Israel, Sept. 24, 2019 /PRNewswire/ -- Tarsius Pharma today announced the acceptance of its Investigational New Drug (IND) application for TRS01 by the U.S. Food and Drug Administration (FDA).The company is developing TRS, a breakthrough, bio-inspired platform technology for the treatment of blinding ocular diseases. TRS was developed to

DALLAS, Sept. 24, 2019 /PRNewswire/ -- BenefitMall, the leading provider of employee benefits and payroll services, today announces the official launch of its latest tool, quote to enroll. Th

PENNINGTON, N.J., Sept. 24, 2019 /PRNewswire/ -- In September, Capital Health became the only hospital in Central New Jersey and the Greater Philadelphia region to offer robotic-assisted Whipple procedures to treat pancreatic cancer. Dr. Cataldo Doria, medical director of the Capital Heal

RESEARCH TRIANGLE PARK, N.C., Sept. 24, 2019 /PRNewswire/ --  Physicians report CivaSheet®, a unidirectional LDR brachytherapy implant made by CivaTech Oncology, demonstrates up to three year local control in recurrent retroperitoneal sarcomas when implanted during surgical resection. The crude cumulative incidence of local recurrence (LR) is 26%. To date,

CHICAGO, Sept. 24, 2019 /PRNewswire/ -- Through the Smoking Cessation for Low-Income Housing Residents project, the American Lung Association helped more than 10,000 residents of public housing quit smoking through enrollment in an evidence-based tobacco cessation program. Funded by the Anthem Foundation, the philanthropic arm of Anthem, Inc., the project offered qu

LONDON, Sept. 24, 2019 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces the launch of its LENS 4K Surgical Imaging System; a state-of-the-art visualization platform designed for end-to-end 4K imaging.

NASHVILLE, Tenn., Sept. 24, 2019 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced FDA Orphan Drug Grant funding for a new Phase II clinical program. The Company has initiated the clinical development of ifetroban for the treatment of cardiomyopathy associated with Duchenne Muscular Dystrophy (DMD). B

LOS ANGELES, Sept. 24, 2019 /PRNewswire/ -- TheraCell Inc., a leading bone solution company today announced that it will launch the world's first ever demineralized bone fiber bon

BOULDER, Colo., Sept. 24, 2019 /PRNewswire/ -- Amplifire is pleased to announce that Bryan Bushick, MD, MBA, has assumed overall responsibility for the company's healthcare-related activities. A seasoned executive and consultant, Dr. Bushick brings experience in population health management, IT-enabled innovation, patient safety and organiz